Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | CTSL | P07711 | 1/20 | 0.46 |
| ▸ | CTSB | P07858 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 1/20 | 0.46 |
| ▸ | LIPE | Q05469 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | PREP | P48147 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9523945 | 0.85 | ALDH1A1 (0.50) | ALDH1A1GAACTSLCTSBCTSK | |
| SCHEMBL3673656 | 0.84 | ALDH1A1 (0.49) | ALDH1A1GAACTSLCTSBCTSK | |
| SCHEMBL7138245 | 0.83 | ALDH1A1 (0.48) | ALDH1A1GAACTSLCTSBCTSK | |
| SCHEMBL2553604 | 0.80 | HTT (0.53) | ALDH1A1GAACTSLCTSBCTSK | |
| SCHEMBL3864756 | 0.80 | HTT (0.53) | ALDH1A1GAACTSLCTSBCTSK | |
| SCHEMBL9381194 | 0.80 | CTSL (0.53) | ALDH1A1GAACTSLCTSBCTSK | |
| SCHEMBL148455 | 0.80 | SMN1; SMN2 (0.70) | SMN1; SMN2NPC1RAB9ACYP2C19 | |
| SCHEMBL27518811 | 0.80 | TSHR (0.46) | ALDH1A1GAACTSLCTSBCTSK | |
| SCHEMBL2558255 | 0.78 | ALDH1A1 (0.71) | ALDH1A1GAACTSLCTSBCTSK | |
| SCHEMBL2558257 | 0.78 | ALDH1A1 (0.71) | ALDH1A1GAACTSLCTSBCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6123964-A | N-(1(R)-((1,2-DIHYDRO-1-METHANESULFONYLSPIRO(3H-INDOLE-3,4' -PIPERDIN)-1'-YL)CARBONYL)-2-(PHENYLMETHYLOXY)ETHYL)-2-AMINO-2-METHYL -PROPANAMIDE, SPECIFIED BINDER/DILUENT, FIRST AND SECOND DILUENTS, DISINTEGRANT, AND LUBRICANT(S); TABLETS | MERCK & CO., INC. (US) | 2000-09-26 | — | — | US | disclosed |
| EP-1019402-A1 | POLYMORPHIC FORMS OF A GROWTH HORMONE SECRETAGOGUE | Merck & Co., Inc. (US) | 2000-07-19 | — | — | EP | disclosed |
| US-6046333-A | Convergent process for the preparation of a growth hormone secretagogue | MERCK & CO., INC. (US) | 2000-04-04 | — | — | US | disclosed |
| US-6028196-A | USING INEXPENSIVE AND ENVIRONMENTALLY ACCEPTABLE STARTING MATERIALS REAGENTS AND SOLVENTS, NO CHROMATOGRAPHIC PURIFICATION OF INTERMEDIATE SPIROINDOLINE SULFONAMIDE TO PRODUCE THE STIMULANTS FOR RELEASING SOMATOTROPIN | MERCK & CO., INC. (US) | 2000-02-22 | — | — | US | disclosed |
| EP-0857020-A4 | WET GRANULATION FORMULATION OF A GROWTH HORMONE SECRETAGOGUE | MERCK & CO INC (US) | 1999-01-07 | — | — | EP | disclosed |
| EP-0863900-A1 | PROCESS FOR THE PREPARATION OF A GROWTH HORMONE SECRETAGOGUE | Merck & Co., Inc. (US) | 1998-09-16 | — | — | EP | disclosed |
| EP-0823904-A4 | PROCESS FOR THE PREPARATION OF SPIROINDOLINES | MERCK & CO INC (US) | 1998-09-09 | — | — | EP | disclosed |
| EP-0857020-A1 | WET GRANULATION FORMULATION OF A GROWTH HORMONE SECRETAGOGUE | Merck & Co., Inc. (US) | 1998-08-12 | — | — | EP | disclosed |
| US-5767124-A | ADMINISTERING TO HUMANS AND ANIMALS TO TREAT PHYSIOLOGICAL OR MEDICAL CONDITIONS CHARACTERIZED BY A DEFICIENCY IN GROWTH HORMONE SECRETION | MERCK & CO., INC. (US) | 1998-06-16 | — | — | US | disclosed |
| WO-1998018815-A1 | CONVERGENT PROCESS FOR THE PREPARATION OF A GROWTH HORMONE SECRETAGOGUE | MERCK & CO., INC. (US) | 1998-05-07 | — | — | WO | disclosed |
| US-5723616-A | Process for the preparation of a growth hormone secretagogue | MERCK & CO., INC. (US) | 1998-03-03 | — | — | US | disclosed |
| EP-0823904-A1 | PROCESS FOR THE PREPARATION OF SPIROINDOLINES | Merck & Co., Inc. (US) | 1998-02-18 | — | — | EP | disclosed |
| WO-1997015191-A1 | WET GRANULATION FORMULATION OF A GROWTH HORMONE SECRETAGOGUE | MERCK & CO., INC. (US) | 1997-05-01 | — | — | WO | disclosed |
| WO-1997015574-A1 | POLYMORPHIC FORMS OF A GROWTH HORMONE SECRETAGOGUE | MERCK & CO., INC. (US) | 1997-05-01 | — | — | WO | disclosed |
| WO-1997015573-A1 | PROCESS FOR THE PREPARATION OF A GROWTH HORMONE SECRETAGOGUE | MERCK & CO., INC. (US) | 1997-05-01 | — | — | WO | disclosed |
| WO-1996033189-A1 | PROCESS FOR THE PREPARATION OF SPIROINDOLINES | MERCK & CO., INC. (US) | 1996-10-24 | — | — | WO | disclosed |